Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Commissioner Kessler to answer retaliation accusations at Nov. 15 House hearing.

This article was originally published in The Tan Sheet

Executive Summary

FDA COMMISSIONER KESSLER TO ADDRESS ALLEGATIONS OF AGENCY RETALIATION at a hearing before Rep. Joe Barton's (R-Tex.) House Commerce/oversight subcommittee on Nov. 15. Commissioner David Kessler is expected to be the lone witness at the session, although he likely will be accompanied by other agency officials, including Center for Devices and Radiological Health Director Bruce Burlington and Associate Commissioner for Regulatory Affairs Ronald Chesmore.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel